
Core Viewpoint - China Everbright Bank's board of directors approved several key resolutions during the 28th meeting of the 9th board, including the distribution of dividends for preferred shares and amendments to the bank's articles of association and meeting rules [1][2][3]. Group 1: Dividend Distribution - The board approved the distribution of cash dividends for the first phase of preferred shares, amounting to RMB 890 million (pre-tax) at a coupon rate of 4.45% for the period from June 25, 2024, to June 24, 2025 [1]. - The board also approved the distribution of cash dividends for the second phase of preferred shares, totaling RMB 401 million (pre-tax) at a coupon rate of 4.01% for the period from August 11, 2024, to August 10, 2025 [2]. - Independent directors confirmed that the proposed dividend distribution plans for both phases align with the bank's actual situation and do not harm the interests of all shareholders, including minority shareholders [2]. Group 2: Governance and Structural Changes - The board approved amendments to the bank's articles of association, rules for shareholder meetings, and rules for board meetings, all receiving unanimous support [2][3]. - The board decided to abolish the supervisory board, with the resolution also receiving unanimous approval [2]. - The board's decisions regarding governance changes will be submitted for approval at the upcoming shareholders' meeting [2]. Group 3: Related Party Transactions - The board approved a comprehensive credit limit for the related entity, Everbright Yongming Life Insurance Co., Ltd., with 11 votes in favor [3]. - A proposal regarding the deposit-related transactions with the related party, Everbright Group Co., Ltd., was also approved with 12 votes in favor [3]. - The board approved a significant related party transaction with China CITIC Financial Asset Management Co., Ltd., receiving 15 votes in favor [3][5]. Group 4: Donations and Reports - The board agreed to donate RMB 13 million to support targeted assistance, which will also be submitted for approval at the shareholders' meeting [5]. - The board approved the submission of the 2024 major shareholder evaluation report to the National Financial Regulatory Administration [5][6]. - The board agreed to convene the 2024 annual shareholders' meeting, with further details to be announced [6].